Fight CRC

Putting Patients First Is in Our Blood

We are dedicated to helping patients at all stages of cancer live longer and healthier lives through the power of our blood tests. Our tests assist at every stage of the cancer journey, from screening, to detect cancer early, to identifying residual and recurring disease in patients with early-stage disease and informing treatment decisions in patients with advanced-stage disease.

We're Here to Listen

Patients are at the heart of our mission and they are the inspiration behind what drives us every day. By connecting with patients and caregivers, we gain insights into the challenges they face at all stages of the journey. Hearing patients’ stories and experiences enables us to make sure we are directly addressing unmet needs in meaningful ways. And sharing these stories enables us to inspire, motivate, and support other patients along the way.


Want to share your story? Fill out our form to get started, or feel free to email us.

Fight CRC

We're Here to Help

Building meaningful collaborations with patient communities and advocacy organizations allows us to educate and support patients with the resources they need and collectively advocate for more research, funding, and access to care.

Our Partnerships

At Guardant Health, we strongly believe in the power of partnership. Here is just a small snapshot of some of our recent work:

Colon Cancer Coalition

Supporting the creation of the Colon Cancer Coalition’s Survivorship Council

We were pleased to support the 2022 launch of the Colon Cancer Coalition’s first Survivorship Council, inclusive of 17 patients, survivors, and caregivers impacted by colorectal cancer, brought together for not only connection and support, but to share their unique perspectives and help inform and improve future awareness and educational efforts in the colorectal cancer treatment and screening space.


Susan G. Komen

Partnering with Susan G. Komen® to develop clinical studies - with an emphasis on uplifting the patient perspective

We've partnered with Susan G. Komen®, the world’s leading breast cancer organization, to develop clinical studies designed to help identify patients with early-stage breast cancer who may benefit from additional monitoring or therapy. A critical element of this partnership is the use of input from patient advocates to guide the research study design -- the Susan G. Komen Advocates in Science will provide first-hand perspective of what matters most to patients. Our collaboration with Susan G. Komen will help researchers understand the value of monitoring for residual or recurring disease in patients treated for breast cancer with the Guardant Reveal™ blood test and aligns with our patient-centered approach.


Fight CRC

Raising awareness of the importance of screening for colorectal cancer in partnership with Fight CRC

With approximately 150,000 new cases of colorectal cancer (CRC) diagnosed each year1 – and it is expected to be the #1 cancer killer of people under 50 by the year 20302 – spreading the word about the value of screening is more critical than ever. In honor of Colorectal Cancer Awareness Month in March, we collaborated with Fight CRC on the development and production of a public service announcement, using real patients and people impacted by the disease to educate others on when to screen, how to screen, and to encourage them to take action with their health.

Watch our video .

We're Here to Share

The cancer landscape is rapidly evolving, and so is our work. We know how important it is to keep the patient community up-to-date on how our research and product portfolio can support their evolving needs.

Our Research and Products

Bringing innovation to the field of cancer care is only possible with strong patient engagement. We are proud to partner with patients to help inform our study designs and to get groundbreaking and quality research underway with leading investigators at medical centers and biopharmaceutical companies to help transform how cancer is detected, treated, and managed.

If you are interested in participating in a study, or you would like to learn more about the breadth and progress of our expanding research, you can view our Clinical Studies. And if you’d like to explore our current product portfolio and see what we are offering patients today, please browse our products.

Our Commitment to Access

We believe all patients deserve access to the healthcare they need. Our Guardant Access program helps patients navigate insurance eligibility, manage claims appeals, answer billing questions, and determine financial assistance eligibility for our tests.

To learn more about how Guardant Access may be able to help you, please contact us.

For Oncology Support:


For Shield™ patient support:

Phone: 1.855.722.7335, ext. 1, then press 2

And to learn more about our commitment to making screening and precision medicine for cancer more accessible to patients, check out our recent news and policy efforts.

Our team

If you’d like to discuss a possible collaboration, learn more about our patient advocacy initiatives, or share your story, please contact our Patient Advocacy Team at